SCHEMBL5262595

SCHEMBL5262595

CC[N]c1ccc([N+](=O)[O-])cc1C(N)=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.51
RAB9A P51151 2/20 0.49
MITF O75030 1/20 0.47
ALDH1A1 P00352 7/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
TP53 P04637 1/20 0.46
HTT P42858 1/20 0.46
PKM P14618 1/20 0.45
NPC1 O15118 1/20 0.44
ATM Q13315 1/20 0.44
LMNA P02545 1/20 0.44
POLB P06746 2/20 0.44
MEN1 O00255 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
TSHR P16473 2/20 0.44
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5264419 0.76 KDM4E (0.41) KMT2AALDH1A1HTTPKMLMNA
SCHEMBL5264746 0.76 ALDH1A1 (0.39) KMT2ARAB9AALDH1A1SMN1; SMN2HTT
SCHEMBL6398309 0.76 KMT2A (0.71) KMT2ARAB9AMITFALDH1A1SMN1; SMN2
SCHEMBL688068 0.75 MAP2K2 (0.37) RAB9AALDH1A1SMN1; SMN2NPC1CYP1A2
SCHEMBL3955084 0.75 KMT2A (0.61) KMT2ARAB9AMITFALDH1A1SMN1; SMN2
SCHEMBL28405139 0.75 KMT2A (0.57) KMT2ARAB9AMITFALDH1A1SMN1; SMN2
SCHEMBL5261896 0.75 KEAP1 (0.40) MAPT
SCHEMBL4437870 0.74 KMT2A (0.60) KMT2ARAB9AMITFALDH1A1SMN1; SMN2
SCHEMBL13844164 0.74 KMT2A (0.60) KMT2ARAB9AMITFALDH1A1SMN1; SMN2
SCHEMBL346217 0.74 KMT2A (0.64) KMT2ARAB9AMITFALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740551-A1 HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF AS AN MMP-13 INHIBITOR Takeda Pharmaceutical Company Limited (JP) 2007-01-10 EP disclosed
WO-2005105760-A1 HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF AS AN MMP-13 INHIBITOR TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-11-10 WO disclosed